Silexion Therapeutics (SLXN) Q4 2024 Earnings

Nov 14Confirmed
Q1 1
Q3 2024
Q4 2024
-7.4
-4.97
-2.54
-0.11

Details

Expected EPS
-7.38
Actual EPS
-7.4
Surprise EPS
-0.02
Surprise Percent
-0.27%

Description

⁨Silexion Therapeutics⁩ (⁦SLXN⁩) has reported earnings of ⁦-7.4⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts